Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Aug 4;89(3):502-4.
doi: 10.1038/sj.bjc.6601113.

Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda

Affiliations

Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda

R Newton et al. Br J Cancer. .

Abstract

A case-control study from Uganda found that the risk of Kaposi's sarcoma increased with increasing titre of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) latent nuclear antigens, independently of HIV infection. Clinically, widespread Kaposi's sarcoma was more frequent among patients with HIV infection than in those without, but was not related to anti-KSHV antibody titres.

PubMed Disclaimer

References

    1. Buchbinder A, Friedman-Kien AE (1991) Clinical aspects of epidemic Kaposi's sarcoma. In Beral V, Jaffe HW, Weiss RA (eds) Cancer, HIV and AIDS. Cancer Surveys. Volume 10. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press - PubMed
    1. Dean AD, Dean JA, Burton JH, Dicker RC (1990) Epi Info Version 5: a word processing, database and statistics program for epidemiology on micro-computers. Centers for Disease Control, Atlanta, Georgia, USA
    1. Newton R, Ziegler J, Beral V, Mbidde E, Carpenter L, Wabinga H, Mbulataiye S, Appleby P, Reeves G, Jaffe H, the Uganda Kaposi's Sarcoma Study Group (2001) A case–control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. Int J Cancer 92: 622–627 - PubMed
    1. Newton R, Ziegler J, Ateenyi-Agaba C, Bousarghin L, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Bourboulia D, Boshoff C, Coursaget P, the Uganda Kaposi's Sarcoma Study Group (2002) The epidemiology of conjunctival squamous cell carcinoma in Uganda. Br J Cancer 87: 301–308 - PMC - PubMed
    1. Newton R, Ziegler J, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, the Uganda Kaposi's Sarcoma Study Group, Weiss R, Boshoff C (2003) The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus in adults with cancer, in Uganda. Int J Cancer 103: 226–232 - PubMed

Publication types

Substances